Hearts and Minds Investments Limited (ASX: HM1) is an Australian listed investment company founded in 2018. It focuses on delivering long-term shareholder returns through high-conviction equity investments while supporting Australian medical research institutes. HM1 manages over $700 million in assets for more than 9,000 shareholders, maintaining a concentrated portfolio of 25–35 global equities selected by leading fund managers. The company employs a dual investment strategy, allocating 65% of its portfolio to ideas from established fund managers and 35% to recommendations from fund managers at the Sohn Hearts & Minds Investment Leaders Conference. HM1 operates on a fee-donation model, directing 100% of its management fees and a portion of performance fees to medical research. This unique approach allows investors to benefit from professional equity exposure while contributing to social impact through philanthropic efforts.